Clinical trialNCT00099619CompletedPhase 3Interventional

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

SponsorAstraZenecaEnrollment138Type 2 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

James Malone, MD
Eli Lilly and Company
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Research Site
Westmead, New South Wales, Australia
Research Site
Daw Park, South Australia, Australia
Research Site
Fullarton, South Australia, Australia
Research Site
Box Hill, Victoria, Australia
Research Site
East Ringwood, Victoria, Australia

Greece

Research Site
Athens, Greece
Research Site
Piraeus, Greece
Research Site
Thessaloniki, Greece

Hungary

Research Site
Budapest, Hungary
Research Site
Gyula, Hungary
Research Site
Pécs, Hungary
Research Site
Veszprém, Hungary
Research Site
Zalaegerszeg, Hungary

Italy

Research Site
Bari, Italy
Research Site
Bergamo, Italy
Research Site
Catania, Italy
Research Site
Milan, Italy
Research Site
Perugia, Italy
Research Site
Rome, Italy

Mexico

Research Site
Guadalajara, Jalisco, Mexico
Research Site
Zapopan, Jalisco, Mexico
Research Site
Monterrey, N.l., Mexico
Research Site
Mexico City, Mexico

Poland

Research Site
Bydgoszcz, Poland
Research Site
Gdansk, Poland
Research Site
Lublin, Poland

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2004
Primary completion: 31 Aug 2005
Completion: 31 Aug 2005
Last update posted: 23 Feb 2015
Registered enrollment: 138
Registry id: NCT00099619

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.